Jai Marathe is an Infectious Disease physician affiliated with Boston University. OpenAlex indexes 41 publications with 1,694 citations (h-index 16).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
43.5%Statin17.6%Rosuvastatin Calcium55%Atorvastatin Calcium46%Part D<11 patientsCalcium channel blocker7.8%Amlodipine Besylate60%Nifedipine Er40%Part D<11 patients+ 4 more classes in this area
Anti-infectives
27.7%Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor9.6%Tivicay100%Part D<11 patientsProtease Inhibitor8.5%Prezcobix78%Symtuza22%Part D<11 patients+ 4 more classes in this area
Metabolism & gastrointestinal
11.3%Proton pump inhibitor4.7%Omeprazole100%Part D<11 patientsBiguanide (metformin)4.3%Metformin Hcl100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Similar KOLs
Other experts from the same institution or the same specialty.
Michael Holick, MD
Boston University
Gene Kwan, MD
Boston University
Joseph Antin, MD
Boston University
George O'Connor, MD
Boston University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”